LipoCoat Wins Extreme Tech Challenge Netherlands & Belgium
Biotech Innovation Award
Fabian Stein
March 28, 2022
Introduction
LipoCoat is proud to be named one of the 3 winners of the finals of the Extreme Tech Challenge Netherlands & Belgium. LipoCoat is one of 3 winners of the finals of the Extreme Tech Challenge Netherlands & Belgium.
LipoCoat is one of 3 winners of the finals of the Extreme Tech Challenge Netherlands & Belgium. LipoCoat is now invited for the global finals in San Francisco in June 2022!The Extreme Tech Challenge is the world's biggest startup competition that aims to help startups that change the world for the better.
Fabian Stein
Business Development & Global Sales
Fabian Stein leads Business Development and Global Sales for the Lipocoat Company, connecting the coating platforms to medical device manufacturers.
Updates
Also interesting
LipoCoat and SonoCoat have earned recognition from leading institutions and regulatory bodies. Our coatings meet the highest standards for biocompatibility and clinical efficacy.
Publication
SonoCoat® Technology Featured in Scientific Publications
Four independent peer-reviewed studies have evaluated SonoCoat®, from EUS-FNA needles to prostate brachytherapy. What each one tested, and what it found.
Document
When the Needle Disappears: SonoCoat® in Three Clinical Applications
Real-time ultrasound guidance is now standard for CVC placement, yet needles still vanish at steep insertion angles. What SonoCoat® changes in vascular access, biopsy and regional anesthesia.
News
TFDA Approves CEMMA and LipoCoat Coated Antifouling CVC Catheter
Taiwan FDA approves CEMMA and LipoCoat co-developed coated antifouling central venous catheter for critical care.